In the zebrafish, Fgf and Hh signalling assign anterior and posterior identity, respectively, to the poles of the developing ear. Mis-expression of
fgf3
or inhibition of Hh signalling results in double-anterior ears, including ectopic expression of
hmx3a
. To understand how this double-anterior pattern is established, we characterised transcriptional responses in Fgf gain-of-signalling or Hh loss-of-signalling backgrounds. Mis-expression of
fgf3
resulted in rapid expansion of anterior otic markers, refining over time to give the duplicated pattern. Response to Hh inhibition was very different: initial anteroposterior asymmetry was retained, with de novo duplicate expression domains appearing later. We show that Hmx3a is required for normal anterior otic patterning, and that otic patterning defects in
hmx3a
-/-
mutants are a close phenocopy to those seen in
fgf3
-/-
mutants. However, neither loss nor gain of
hmx3a
function was sufficient to generate full ear duplications. Using our data to infer a transcriptional regulatory network required for acquisition of otic anterior identity, we can recapitulate both the wild-type and the double-anterior pattern in a mathematical model.
23In the zebrafish, Fgf and Hh signalling assign anterior and posterior identity, 24 respectively, to the poles of the developing ear. Mis-expression of fgf3 or inhibition of 25Hh signalling results in double-anterior ears, including ectopic expression of hmx3a. 26To understand how this double-anterior pattern is established, we characterised 27 transcriptional responses in Fgf gain-of-signalling or Hh loss-of-signalling 28 backgrounds. Mis-expression of fgf3 resulted in rapid expansion of anterior otic 29
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.